ZANVASTRO
Live / Applied — New application — assigned to an examiner (as of 02 Apr 2026)
What this means for you
Not registered yet, but its 18 Nov 2025 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 99503014
- Mark type
- Design + words
- Filed
- 18 Nov 2025
- Attorney of record
- Paul C. Llewellyn
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations and substances for the treatment of neurodevelopmental and neurodegenerative diseases and disorders, leukodystrophy, demyelinating diseases and disorders, and hypomyelinating diseases and disorders; Pharmaceutical preparations and substances for the treatment of glial fibrillary acidic protein-associated diseases and disorders, Alexander Disease, seizures, ataxia, motor function disorders, cognitive function disorders, dysphagia, and swallowing disorders; Pharmaceutical preparations and substances for the treatment of autosomal dominant, autosomal recessive, genetic, neurologic, parasympathetic system, neuromuscular system, skeletomuscular system, central nervous system, epileptic, pulmonary, respiratory, ophthalmic, gastrointestinal, skin, metabolic, autoimmune and lymphoproliferative diseases and disorders; Pharmaceutical preparations containing zilganersen.
- Class 044 — Medical, beauty and agricultural services: Providing health information; providing healthcare information; medical information services provided via the Internet
Owner
- Ionis Pharmaceuticals, Inc., Carlsbad, CA, US
Prosecution history
- 02 Apr 2026 — ASSIGNED TO EXAMINER
- 01 Apr 2026 — NOTICE OF DESIGN SEARCH CODE E-MAILED
- 01 Apr 2026 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 18 Nov 2025 — APPLICATION FILING RECEIPT MAILED
- 18 Nov 2025 — NEW APPLICATION ENTERED